Journal ArticleOPEN ACCESS

Myeloablative chemotherapy in testicular cancer patient

  • Furgała K
  • Smuniewska Z
  • Sigorski D
  • et al.
OncoReview (2021) 11(1(41)) 19-21
DOI: 10.24292/01.or.121030321
N/ACitations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

Chemotherapy is the standard treatment for metastatic testicular cancers. The autologous hematopoietic stem cell transplantation is a salvage option for relapsed patients. The paper presents a case of a 20-year-old patient with stage IIIC non-seminoma treated with BEP chemotherapy and autologous transplantation of stem cells, which allowed to achieve durable remission.

Cite

CITATION STYLE

APA

Furgała, K., Smuniewska, Z., Sigorski, D., Michalak, M., & Bodnar, L. (2021). Myeloablative chemotherapy in testicular cancer patient. OncoReview, 11(1(41)), 19–21. https://doi.org/10.24292/01.or.121030321

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free